1-1 of 1
Alexander Shimabokuro-Vornhagen
Close
Sort by
Journal Articles

MGN1703, a Novel TLR9-Agonist - Results of a Phase 1 Clinical Trial in Patients with Metastatic Malignancies.

Martin R Weihrauch, Manuel Schmidt, Marina Tschaika, Heike Richly, Michael S von Bergwelt-Baildon, Ulrich Hacker, Alexander Shimabokuro-Vornhagen, Burghardt Wittig, Max E Scheulen
Journal: Blood
Blood (2009) 114 (22): 4730.
https://doi.org/10.1182/blood.V114.22.4730.4730
Published: 2009